Alpheus Medical

Alpheus Medical

Signal active

Organization

Contact Information

Overview

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers. Alpheus Medical also provides a non-invasive drug-device combination for outpatient treatment of recurrent glioblastoma multiforme (rGBM).

About

Industries

Biotechnology, Health Care, Medical, Health Diagnostics

Founded

2021

Employees

1-10

Headquarters locations

Oakdale, Pennsylvania, United States, North America

Social

Profile Resume

Alpheus Medical headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Health Diagnostics sector. The company focuses on Biotechnology and has secured $960.0M in funding across 32 round(s). With a team of 1-10 employees, Alpheus Medical is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Alpheus Medical, raised $14.0M. Discover more about their projects, partnerships, and impact on our platform.

Employees

imagePlace Vijay Agarwal

Vijay Agarwal

Founder, President and CEO

imagePlace Jeremy Ling

Jeremy Ling

Chief Technology Officer

Funding Rounds

Funding rounds

2

Investors

5

Lead Investors

0

Total Funding Amount

$30.0M

Details

2

Alpheus Medical has raised a total of $30.0M in funding over 2 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2021Early Stage Venture16.0M
2022Early Stage Venture14.0M

Investors

Alpheus Medical is funded by 17 investors.

Investor NameLead InvestorFunding RoundPartners
Medtech Convergence Fund-FUNDING ROUND - Medtech Convergence Fund14.0M
BrightEdge Fund-FUNDING ROUND - BrightEdge Fund14.0M
Alpheus Medical-FUNDING ROUND - Alpheus Medical14.0M
SV Health Investors-FUNDING ROUND - SV Health Investors14.0M